脊椎融合手术:市场洞察·流行病学·市场预测 (～2034年)

本报告考察了全球七个主要国家的脊椎融合术市场，包括疾病背景/概述、流行病学、治疗和管理概述、市场驱动因素和障碍、未满足的需求、上市药物和管道。国家的市场规模趋势和预测、竞争格局等，以发现最佳机会并评估市场潜力。

目标区域

• 美国
• 5 个欧洲国家（德国、法国、义大利、西班牙、英国）
• 日本

调查期间：2020-2034年

报告要点

• 由于人们对该疾病的认识不断提高以及全球医疗保健支出的增加，预计脊椎融合手术市场将在未来几年出现变化。
• 公司和研究机构正在努力分析可能影响脊椎融合研究和开发的课题并探索机会。正在开发的疗法着重于治疗/改善疾病状况的新方法。
• 各大公司正致力于开发治疗脊椎融合手术的药物。新治疗药物的推出预计将对市场产生重大影响。
• 开发用于脊椎融合手术的新治疗剂需要对疾病病理学有更深入的了解。
• 按开发阶段（第III 期和第II 期）对我们的管道资产进行详细分析，包括各种新兴趋势、详细的临床概况、关键交叉竞争、上市日期和产品线药物开发活动比较分析，从而帮助客户进行产品开发活动。

目录

第1章 重要的洞察

第2章 脊椎融合手术:摘要整理

第3章 脊椎融合手术:竞争资讯分析

第4章 脊椎融合手术:市场概要

• 整体市场占有率 (%) 的分布:2020年
• 整体市场占有率 (%) 的分布:2034年

第5章 脊椎融合手术:疾病的背景·概要

• 征兆与症状
• 病理生理学
• 风险因素
• 诊断

第6章 病人历程

第7章 脊椎融合手术:流行病学·患者人口

• 流行病学:主要调查结果
• 前提·根据:主要7个国家
• 流行病学Scenario:主要7个国家
  • 主要7个国家的脊椎融合手术的流行病学Scenario:2020-2034年
• 流行病学:美国
• 流行病学:欧洲5个国家
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 英国
• 流行病学:日本

第8章 治疗流程·目前治疗·医疗行为

• 脊椎融合手术的治疗和管理
• 脊椎融合手术的治疗流程

第9章 未满足需求

第10章 脊椎融合手术治疗主要的端点

第11章 已上市产品

• 主要7个国家的上市产品清单
• 医药品名·企业名
  • 产品说明
  • 法规的里程碑
  • 其他的开发活动
  • 重要临床试验
  • 主要临床试验概要

第12章 新治疗方法

• 主要的交叉竞争
• 医药品名·企业名
  • 产品说明
  • 其他的开发活动
  • 临床开发
  • 安全性和有效性
  • 产品简介

第13章 市场分析脊椎融合手术:主要7个国家

• 主要调查结果
• 主要7个国家的市场规模
• 主要7个国家的市场规模:各治疗药物

第14章 属性分析

第15章 主要7个国家:市场展望

• 美国:市场规模
• 欧洲5个国家:市场规模·展望
• 德国
• 法国
• 义大利
• 西班牙
• 英国
• 日本市场展望

第16章 与脊椎融合手术:存取(点阅)偿付概要

第17章 KOL的见解

第18章 推动市场要素

第19章 市场障碍

第20章 附录

第21章 DelveInsight的能力

第22章 免责声明

第23章 关于DelveInsight

DelveInsight's "Spinal Fusion - Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Spinal Fusion, historical and forecasted epidemiology as well as the Spinal Fusion market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Spinal Fusion market report provides current treatment practices, emerging drugs, Spinal Fusion market share of the individual therapies, current and forecasted Spinal Fusion market size from 2020 to 2034 segmented by seven major markets. The Report also covers current Spinal Fusion treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Geography Covered:

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2020-2034

Spinal Fusion Disease Understanding and Treatment Algorithm

The DelveInsight Spinal Fusion market report gives a thorough understanding of the Spinal Fusion by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment.

Diagnosis

This segment of the report covers the detailed diagnostic methods or tests for Spinal Fusion.

Treatment

It covers the details of conventional and current medical therapies available in the Spinal Fusion market for the treatment of the condition. It also provides Spinal Fusion treatment algorithms and guidelines in the United States, Europe, and Japan.

Spinal Fusion Epidemiology

The Spinal Fusion epidemiology division provide insights about historical and current Spinal Fusion patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Spinal Fusion epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2020 to 2034.

Country Wise-Spinal Fusion Epidemiology

The epidemiology segment also provides the Spinal Fusion epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Spinal Fusion Drug Chapters

Drug chapter segment of the Spinal Fusion report encloses the detailed analysis of Spinal Fusion marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Spinal Fusion clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Marketed Drugs

The report provides the details of the marketed product available for Spinal Fusion treatment.

Spinal Fusion Emerging Drugs

The report provides the details of the emerging therapies under the late and mid-stage of development for Spinal Fusion treatment.

Spinal Fusion Market Outlook

The Spinal Fusion market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Spinal Fusion market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

This segment gives a thorough detail of Spinal Fusion market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, Spinal Fusion market in 7MM is expected to change in the study period 2020-2034.

Key Findings

This section includes a glimpse of the Spinal Fusion market in 7MM.

The United States Market Outlook

This section provides the total Spinal Fusion market size and market size by therapies in the United States.

EU-5 Countries: Market Outlook

The total Spinal Fusion market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.

Japan Market Outlook

The total Spinal Fusion market size and market size by therapies in Japan is also mentioned.

Spinal Fusion Drugs Uptake

This section focusses on the rate of uptake of the potential drugs recently launched in the Spinal Fusion market or expected to get launched in the market during the study period 2020-2034. The analysis covers Spinal Fusion market uptake by drugs; patient uptake by therapies; and sales of each drug.

This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Spinal Fusion Pipeline Development Activities

The report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Spinal Fusion key players involved in developing targeted therapeutics.

Pipeline Development Activities

The report covers the detailed information of collaborations, acquisition and merger, licensing, patent details and other information for Spinal Fusion emerging therapies.

Reimbursement Scenario in Spinal Fusion

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.

KOL- Views

To keep up with current market trends, we take KOLs and SME's opinion working in Spinal Fusion domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Spinal Fusion market trend. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.

Competitive Intelligence Analysis

We perform Competitive and Market Intelligence analysis of the Spinal Fusion Market by using various Competitive Intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.

Scope of the Report:

• The report covers the descriptive overview of Spinal Fusion, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Spinal Fusion epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Spinal Fusion are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of Spinal Fusion market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Spinal Fusion market

Report Highlights:

• In the coming years, Spinal Fusion market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
• The companies and academics are working to assess challenges and seek opportunities that could influence Spinal Fusion R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
• Major players are involved in developing therapies for Spinal Fusion. Launch of emerging therapies will significantly impact the Spinal Fusion market
• A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Spinal Fusion
• Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Spinal Fusion Report Insights

• Patient Population
• Therapeutic Approaches
• Spinal Fusion Pipeline Analysis
• Spinal Fusion Market Size and Trends
• Market Opportunities
• Impact of upcoming Therapies

Spinal Fusion Report Key Strengths

• 11 Years Forecast
• 7MM Coverage
• Spinal Fusion Epidemiology Segmentation
• Key Cross Competition
• Highly Analyzed Market
• Drugs Uptake

Spinal Fusion Report Assessment

• Current Treatment Practices
• Unmet Needs
• Pipeline Product Profiles
• Market Attractiveness
• Market Drivers and Barriers

Key Questions:

Market Insights:

• What was the Spinal Fusion market share (%) distribution in 2020 and how it would look like in 2034?
• What would be the Spinal Fusion total market size as well as market size by therapies across the 7MM during the forecast period (2024-2034)?
• What are the key findings pertaining to the market across 7MM and which country will have the largest Spinal Fusion market size during the forecast period (2024-2034)?
• At what CAGR, the Spinal Fusion market is expected to grow in 7MM during the forecast period (2020-2034)?
• What would be the Spinal Fusion market outlook across the 7MM during the forecast period (2020-2034)?
• What would be the Spinal Fusion market growth till 2032, and what will be the resultant market Size in the year 2034?
• How would the market drivers, barriers and future opportunities affect the market dynamics and subsequent analysis of the associated trends?

Epidemiology Insights:

• What is the disease risk, burden and unmet needs of the Spinal Fusion?
• What is the historical Spinal Fusion patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What would be the forecasted patient pool of Spinal Fusion in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Spinal Fusion?
• Out of all 7MM countries, which country would have the highest prevalent population of Spinal Fusion during the forecast period (2020-2034)?
• At what CAGR the population is expected to grow in 7MM during the forecast period (2020-2034)?

Current Treatment Scenario, Marketed Drugs and Emerging Therapies:

• What are the current options for the Spinal Fusion treatment, along with the approved therapy?
• What are the current treatment guidelines for the treatment of Spinal Fusion in the USA, Europe, and Japan?
• What are the Spinal Fusion marketed drugs and their MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?
• How many companies are developing therapies for the treatment of Spinal Fusion?
• How many therapies are developed by each company for Spinal Fusion treatment?
• How many are emerging therapies in mid-stage, and late stage of development for Spinal Fusion treatment?
• What are the key collaborations (Industry - Industry, Industry - Academia), Mergers and acquisitions, licensing activities related to the Spinal Fusion therapies?
• What are the recent novel therapies, targets, mechanisms of action and technologies developed to overcome the limitation of existing therapies?
• What are the clinical studies going on for Spinal Fusion and their status?
• What are the key designations that have been granted for the emerging therapies for Spinal Fusion?
• What are the global historical and forecasted market of Spinal Fusion?

Reasons to buy:

• The report will help in developing business strategies by understanding trends shaping and driving the Spinal Fusion market
• To understand the future market competition in the Spinal Fusion market and Insightful review of the key market drivers and barriers
• Organize sales and marketing efforts by identifying the best opportunities for Spinal Fusion in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
• Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for Spinal Fusion market
• To understand the future market competition in the Spinal Fusion market

Table of Contents

1. Key Insights

2. Executive Summary of Spinal Fusion

3. Competitive Intelligence Analysis for Spinal Fusion

4. Spinal Fusion: Market Overview at a Glance

• 4.1. Spinal Fusion Total Market Share (%) Distribution in 2020
• 4.2. Spinal Fusion Total Market Share (%) Distribution in 2034

5. Spinal Fusion: Disease Background and Overview

• 5.1. Introduction
• 5.2. Sign and Symptoms
• 5.3. Pathophysiology
• 5.4. Risk Factors
• 5.5. Diagnosis

6. Patient Journey

7. Spinal Fusion Epidemiology and Patient Population

• 7.1. Epidemiology Key Findings
• 7.2. Assumptions and Rationale: 7MM
• 7.3. Epidemiology Scenario: 7MM
  • 7.3.1. Spinal Fusion Epidemiology Scenario in the 7MM (2020-2034)
• 7.4. United States Epidemiology
  • 7.4.1. Spinal Fusion Epidemiology Scenario in the United States (2020-2034)
• 7.5. EU-5 Country-wise Epidemiology
  • 7.5.1. Germany Epidemiology
    • 7.5.1.1. Spinal Fusion Epidemiology Scenario in Germany (2020-2034)
  • 7.5.2. France Epidemiology
    • 7.5.2.1. Spinal Fusion Epidemiology Scenario in France (2020-2034)
  • 7.5.3. Italy Epidemiology
    • 7.5.3.1. Spinal Fusion Epidemiology Scenario in Italy (2020-2034)
  • 7.5.4. Spain Epidemiology
    • 7.5.4.1. Spinal Fusion Epidemiology Scenario in Spain (2020-2034)
  • 7.5.5. United Kingdom Epidemiology
    • 7.5.5.1. Spinal Fusion Epidemiology Scenario in the United Kingdom (2020-2034)
  • 7.5.6. Japan Epidemiology
    • 7.5.6.1. Spinal Fusion Epidemiology Scenario in Japan (2020-2034)

8. Treatment Algorithm, Current Treatment, and Medical Practices

• 8.1. Spinal Fusion Treatment and Management
• 8.2. Spinal Fusion Treatment Algorithm

9. Unmet Needs

10. Key Endpoints of Spinal Fusion Treatment

11. Marketed Products

• 11.1. List of Marketed Products in the 7MM
• 11.2. Drug Name: Company Name
  • 11.2.1. Product Description
  • 11.2.2. Regulatory Milestones
  • 11.2.3. Other Developmental Activities
  • 11.2.4. Pivotal Clinical Trials
  • 11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Emerging Therapies

• 12.1. Key Cross
• 12.2. Drug Name: Company Name
  • 12.2.1. Product Description
  • 12.2.2. Other Developmental Activities
  • 12.2.3. Clinical Development
  • 12.2.4. Safety and Efficacy
  • 12.2.5. Product Profile

List to be continued in report

13. Spinal Fusion: Seven Major Market Analysis

• 13.1. Key Findings
• 13.2. Spinal Fusion Market Size in 7MM
• 13.3. Spinal Fusion Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

• 15.1. United States: Market Size
  • 15.1.1. Spinal Fusion Total Market Size in the United States
  • 15.1.2. Spinal Fusion Market Size by Therapies in the United States
• 15.2. EU-5 countries: Market Size and Outlook
• 15.3. Germany Market Size
  • 15.3.1. Spinal Fusion Total Market Size in Germany
  • 15.3.2. Spinal Fusion Market Size by Therapies in Germany
• 15.4. France Market Size
  • 15.4.1. Spinal Fusion Total Market Size in France
  • 15.4.2. Spinal Fusion Market Size by Therapies in France
• 15.5. Italy Market Size
  • 15.5.1. Spinal Fusion Total Market Size in Italy
  • 15.5.2. Spinal Fusion Market Size by Therapies in Italy
• 15.6. Spain Market Size
  • 15.6.1. Spinal Fusion Total Market Size in Spain
  • 15.6.2. Spinal Fusion Market Size by Therapies in Spain
• 15.7. United Kingdom Market Size
  • 15.7.1. Spinal Fusion Total Market Size in the United Kingdom
  • 15.7.2. Spinal Fusion Market Size by Therapies in the United Kingdom
• 15.8. Japan Market Outlook
  • 15.8.1. Japan Market Size
  • 15.8.2. Spinal Fusion Total Market Size in Japan
  • 15.8.3. Spinal Fusion Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Spinal Fusion

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

• 20.1. Bibliography
• 20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

The table of contents is not exhaustive; the final content may vary.

List of Tables

• Table 1: 7MM Spinal Fusion Epidemiology (2020-2034)
• Table 2: 7MM Spinal Fusion Diagnosed and Treatable Cases (2020-2034)
• Table 3: Spinal Fusion Epidemiology in the United States (2020-2034)
• Table 4: Spinal Fusion Diagnosed and Treatable Cases in the United States (2020-2034)
• Table 5: Spinal Fusion Epidemiology in Germany (2020-2034)
• Table 6: Spinal Fusion Diagnosed and Treatable Cases in Germany (2020-2034)
• Table 7: Spinal Fusion Epidemiology in France (2020-2034)
• Table 8: Spinal Fusion Diagnosed and Treatable Cases in France (2020-2034)
• Table 9: Spinal Fusion Epidemiology in Italy (2020-2034)
• Table 10: Spinal Fusion Diagnosed and Treatable Cases in Italy (2020-2034)
• Table 11: Spinal Fusion Epidemiology in Spain (2020-2034)
• Table 12: Spinal Fusion Diagnosed and Treatable Cases in Spain (2020-2034)
• Table 13: Spinal Fusion Epidemiology in the UK (2020-2034)
• Table 14: Spinal Fusion Diagnosed and Treatable Cases in the UK (2020-2034)
• Table 15: Spinal Fusion Epidemiology in Japan (2020-2034)
• Table 16: Spinal Fusion Diagnosed and Treatable Cases in Japan (2020-2034)
• Table 17: Drug Name, Clinical Trials by Recruitment status
• Table 18: Drug Name, Clinical Trials by Zone
• Table 19: Total Seven Major Market Size in USD, Million (2020-2034)
• Table 20: Region-wise Market Size in USD, Million (2020-2034)
• Table 21: 7MM-Market Size by Therapy in USD, Million (2020-2034)
• Table 22: United States Market Size in USD, Million (2020-2034)
• Table 23: United States Market Size by Therapy in USD, Million (2020-2034)
• Table 24: Germany Market Size in USD, Million (2020-2034)
• Table 25: Germany Market Size by Therapy in USD, Million (2020-2034)
• Table 26: France Market Size in USD, Million (2020-2034)
• Table 27: France Market Size by Therapy in USD, Million (2020-2034)
• Table 28: Italy Market Size in USD, Million (2020-2034)
• Table 29: Italy Market Size by Therapy in USD, Million (2020-2034)
• Table 30: Spain Market Size in USD, Million (2020-2034)
• Table 31: Spain Market Size by Therapy in USD, Million (2020-2034)
• Table 32: United Kingdom Market Size in USD, Million (2020-2034)
• Table 33: United Kingdom Market Size by Therapy in USD, Million (2020-2034)
• Table 34: Japan Market Size in USD, Million (2020-2034)
• Table 35: Japan Market Size by Therapy in USD, Million (2020-2034)

The list of tables is not exhaustive; the final content may vary

List of Figures

• Figure 1: 7MM Spinal Fusion Epidemiology (2020-2034)
• Figure 2: 7MM Spinal Fusion Diagnosed and Treatable Cases (2020-2034)
• Figure 3: Spinal Fusion Epidemiology in the United States (2020-2034)
• Figure 4: Spinal Fusion Diagnosed and Treatable Cases in the United States (2020-2034)
• Figure 5: Spinal Fusion Epidemiology in Germany (2020-2034)
• Figure 6: Spinal Fusion Diagnosed and Treatable Cases in Germany (2020-2034)
• Figure 7: Spinal Fusion Epidemiology in France (2020-2034)
• Figure 8: Spinal Fusion Diagnosed and Treatable Cases in France (2020-2034)
• Figure 9: Spinal Fusion Epidemiology in Italy (2020-2034)
• Figure 10: Spinal Fusion Diagnosed and Treatable Cases in Italy (2020-2034)
• Figure 11: Spinal Fusion Epidemiology in Spain (2020-2034)
• Figure 12: Spinal Fusion Diagnosed and Treatable Cases in Spain (2020-2034)
• Figure 13: Spinal Fusion Epidemiology in the UK (2020-2034)
• Figure 14: Spinal Fusion Diagnosed and Treatable Cases in the UK (2020-2034)
• Figure 15: Spinal Fusion Epidemiology in Japan (2020-2034)
• Figure 16: Spinal Fusion Diagnosed and Treatable Cases in Japan (2020-2034)
• Figure 17: Drug Name, Clinical Trials by Recruitment status
• Figure 18: Drug Name, Clinical Trials by Zone
• Figure 19: Total Seven Major Market Size in USD, Million (2020-2034)
• Figure 20: Region-wise Market Size in USD, Million (2020-2034)
• Figure 21: 7MM-Market Size by Therapy in USD, Million (2020-2034)
• Figure 22: United States Market Size in USD, Million (2020-2034)
• Figure 23: United States Market Size by Therapy in USD, Million (2020-2034)
• Figure 24: Germany Market Size in USD, Million (2020-2034)
• Figure 25: Germany Market Size by Therapy in USD, Million (2020-2034)
• Figure 26: France Market Size in USD, Million (2020-2034)
• Figure 27: France Market Size by Therapy in USD, Million (2020-2034)
• Figure 28: Italy Market Size in USD, Million (2020-2034)
• Figure 29: Italy Market Size by Therapy in USD, Million (2020-2034)
• Figure 30: Spain Market Size in USD, Million (2020-2034)
• Figure 31: Spain Market Size by Therapy in USD, Million (2020-2034)
• Figure 32: United Kingdom Market Size in USD, Million (2020-2034)
• Figure 33: United Kingdom Market Size by Therapy in USD, Million (2020-2034)
• Figure 34: Japan Market Size in USD, Million (2020-2034)
• Figure 35: Japan Market Size by Therapy in USD, Million (2020-2034)

The list of figures is not exhaustive; the final content may vary